NEW YORK (GenomeWeb) – Veracyte today said it has launched an early-access program for its Envisia Genomic Classifier test for idiopathic pulmonary fibrosis. The test uses RNA sequencing and machine learning to analyze 190 genes involved in usual interstitial pneumonia, a feature of IPF, with 88 percent specificity and 70 percent sensitivity.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oct
02

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
10

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.